Avoid common mistakes on your manuscript.
To the Editor: The second wave of COVID-19, outnumbered the first, in terms of cases and deaths [1]. Global data have been variable with respect to mortality (0–6.6%) [2]. We report outcome of patients with COVID-19 during the second wave from the pediatric oncology unit of a tertiary care center in India.
Pediatric cancer patients, testing positive for SARS-CoV-2 were enrolled. Data on symptoms, hematological/inflammatory parameters, treatment, and outcome were collected. All cases were followed up till tested negative.
Forty-one patients (23 ALL, 5 Ewing sarcoma, 3 retinoblastoma, 2 each of AML/neuroblastoma/non-Hodgkin lymphoma, and 1 each of Hodgkin lymphoma/LCH/ rhabdomyosarcoma/nasopharyngeal carcinoma) tested positive for SARS-CoV-2. While more than half were asymptomatic, 36% had mild symptoms. Twenty-five (60.9%) patients improved on home isolation, 12 were admitted in ward, and 4 in ICU. Out of 5 patients that required supplemental oxygen, 4 needed mechanical ventilation. Systemic steroids and remdesivir were given in 4 and 2 patients, respectively. While hematological parameters were normal in majority, inflammatory markers: CRP, Ferritin, IL-6 and D-dimer were elevated. The mean time to negativity was 18 d, but 5 patients tested negative after 1 mo with the maximum time to negativity being 46 d.
Of the 4 deaths, 1 occurred due to terminal cancer, and rest 3 (7.3%) COVID-attributed deaths occurred in adolescent patients and 2 had superimposed bacterial/viral infections. Two patients were treated with IVIG for MIS-C. Additional contributors to mortality were: severe thinness, superior mediastinal syndrome, disease relapse. None of our patients had any nononcological risk factors.
Although the rate of severe COVID-19 in our study (10%) is somewhat similar to other developed countries, 7.3% COVID-related deaths in our cohort is higher than those of the developed nations [3]. Pediatric cancer patients in developing countries might be at increased risk of superinfections, severe disease, and death.
References
Worldometer. Coronavirus. Available at: https://www.worldometers.info/coronavirus/country/india/. Accessed on 4 June 2021.
Millen GC, Arnold R, Cazier JB, et al. Severity of COVID-19 in children with cancer: report from the United Kingdom Paediatric Coronavirus Cancer Monitoring Project. Br J Cancer. 2021;124:754–9.
Madhusoodhan PP, Pierro J, Musante J, et al. Characterization of COVID-19 disease in pediatric oncology patients: The New York-New Jersey regional experience. Pediatr Blood Cancer. 2021;68:e28843.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
None.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Mohapatra, D., Prabhakar, P., Seth, R. et al. Clinicoepidemiological Profile and Outcome of SARS-CoV-2 Infection in a Cohort of Pediatric Cancer Patients During the Second Wave in India. Indian J Pediatr 89, 624 (2022). https://doi.org/10.1007/s12098-022-04133-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12098-022-04133-z